Home/Investors/Sinovation Ventures

Sinovation Ventures

Biotech Investor · 12 portfolio companies

Portfolio

12

Focus Areas

8

Top Stage

phase-1

Investment Focus

Metabolic Oncology Metabolic Diseases Genetics Immunology Infectious Disease Genetics & Genomics Vaccines

Portfolio Companies

Company	Stage	Valuation	Focus
Evive Biotech	phase-2	—	Metabolic
Conjustar	phase-1	—	Oncology
Delova Biotech	phase-1	—	Oncology
Raffles PharmaTech	phase-2	—	Oncology, Metabolic Diseases
Westlake Genetech	commercial	—	Genetics, Oncology
Kanglin Biotechnology	phase-1	—	Oncology, Immunology
Bliss Biopharmaceutical	phase-1	—	Oncology
Magpie Pharmaceuticals	preclinical	—	Oncology
Biokey	commercial	—	Infectious Disease, Genetics & Genomics
Therorna	phase-3	—	Infectious Disease, Vaccines
BriSTAR Immunotech	phase-1	—	Oncology, Immunology
Avistone	phase-2	—	Oncology

Frequent Co-Investors

OrbiMed Asia5 shared Lilly Asia Ventures3 shared GL Ventures3 shared Qiming Venture Partners2 shared TF Capital2 shared Temasek2 shared 3H Health Investment2 shared Legend Capital1 shared